HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$2.30
Day range
$2.17 - $2.36
Year range
$0.89 - $5.33
Market cap
56.60M USD
Avg Volume
257.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.18M | -9.73% |
Net income | -4.49M | 4.93% |
Net profit margin | — | — |
Earnings per share | -0.17 | 54.05% |
EBITDA | -4.45M | 8.78% |
Effective tax rate | -0.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.05M | -1.50% |
Total assets | 14.37M | 1.90% |
Total liabilities | 5.46M | -19.37% |
Total equity | 8.91M | — |
Shares outstanding | 26.53M | — |
Price to book | 6.76 | — |
Return on assets | -66.43% | — |
Return on capital | -100.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.49M | 4.93% |
Cash from operations | -6.08M | -53.18% |
Cash from investing | -1.00 | -100.00% |
Cash from financing | 808.68K | 501.37% |
Net change in cash | -4.88M | -138.50% |
Free cash flow | -4.42M | -129.42% |
About
Founded
2017
Website
Employees
31
